ResearcherZhengzhou UniversityActive in the last 2 years

Jufeng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5933-2152; OpenAlex author ID A5101972293. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma… Co-author DOI 10.1038/s41392-024-01948-4 ↗
Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma. Last author DOI 10.21037/jgo-21-613 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qian Li · 1 shared paper, 2021 · strength 0.19
- Paper Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma. DOI 10.21037/jgo-21-613 ↗
Chuntao Gao · 1 shared paper, 2024 · strength 0.15
- Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4 ↗
Jiuwei Cui · 1 shared paper, 2024 · strength 0.15
- Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4 ↗
Jun Yao · 1 shared paper, 2024 · strength 0.15
- Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4 ↗
Liwei Wang · 1 shared paper, 2024 · strength 0.15
- Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4 ↗
Zhihua Li · 1 shared paper, 2024 · strength 0.15
- Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4 ↗
Tao Xia · 1 shared paper, 2024 · strength 0.15
- Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4 ↗
Yuhong Zhou · 1 shared paper, 2024 · strength 0.15
- Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4 ↗
Jiujie Cui · 1 shared paper, 2024 · strength 0.15
- Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4 ↗
Deliang Fu · 1 shared paper, 2024 · strength 0.15
- Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4 ↗
Shukui Qin · 1 shared paper, 2024 · strength 0.15
- Paper Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or met… DOI 10.1038/s41392-024-01948-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.